Cerence (CRNC) director Douglas Davis awarded 12,968 RSUs

Rhea-AI Filing Summary

Cerence Inc. director Douglas Lee Davis acquired 12,968 shares of common stock as a restricted stock unit award on February 12, 2026 at a price of $0.01 per share. Following this grant, he directly beneficially owns 39,544 common shares.

The RSUs will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence’s next fiscal year Annual General Meeting, aligning the director’s compensation with future company performance.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DAVIS DOUGLAS LEE

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	12,968	$0.01	$129.68

Holdings After Transaction: Common Stock — 39,544 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DAVIS DOUGLAS LEE

(Last) (First) (Middle)

25 MALL ROAD

SUITE 416

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/12/2026		A		12,968(1)	A	$0.01	39,544	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The RSUs shall vest on the earlier of: (i) the first anniversary of the Date of Grant; or (ii) the day immediately prior to the Company's next fiscal year's Annual General Meeting.

Remarks:

	/s/ Jennifer Salinas, Attorney-in-Fact	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cerence (CRNC) report for Douglas Lee Davis?

Douglas Lee Davis received a grant of 12,968 Cerence common shares as a restricted stock unit award at $0.01 per share. This equity award increases his direct beneficial ownership to 39,544 shares, reflecting part of his compensation as a member of Cerence’s board of directors.

When did the Douglas Lee Davis Form 4 transaction at Cerence (CRNC) occur?

The reported Cerence insider transaction took place on February 12, 2026. On that date, director Douglas Lee Davis was granted 12,968 restricted stock units at $0.01 per share, as disclosed in the Form 4 insider trading report filed with regulators.

How many Cerence (CRNC) shares does Douglas Lee Davis own after this Form 4?

After the February 12, 2026 grant, Douglas Lee Davis beneficially owns 39,544 Cerence shares directly. This total includes the newly awarded 12,968 restricted stock units, reflecting his equity stake as a director of Cerence Inc. following the reported transaction.

What is the vesting schedule for Douglas Lee Davis’s new Cerence (CRNC) RSUs?

The 12,968 RSUs vest on the earlier of two dates. They vest either on the first anniversary of the grant date or the day immediately prior to Cerence’s next fiscal year Annual General Meeting, whichever comes first, tying vesting to board service timing.

Was the Cerence (CRNC) Douglas Lee Davis transaction a purchase or an award?

The Cerence transaction for Douglas Lee Davis was an equity award, not an open-market purchase. The Form 4 lists transaction code “A,” indicating a grant or other acquisition of 12,968 restricted stock units at a nominal price of $0.01 per share.